FindTrial
Sign In

Seroprevalence and Influencing Factors of HPV Neutralizing Antibodies in Gynecological Outpatients: A Large-Sample Cross-Sectional Study

Seroprevalence and Influencing Factors of HPV Neutralizing Antibodies in Gynecological Outpatients: A Large-Sample Cross-Sectional Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500113157
Enrollment
Unknown
Registered
2025-11-25
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecological Outpatients

Interventions

Observational group:None

Sponsors

The Second Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Willing and able to provide informed consent. 2.Females, 18-65 years of age (inclusive). 3.Documented HPV DNA test result within the past 6 months.

Exclusion criteria

Exclusion criteria: 1.Contraindicated for or unwilling to undergo blood draw. 2.Unwilling to provide informed consent for study participation. 3.Age 65 years.

Design outcomes

Primary

MeasureTime frame
Distribution of HPV Neutralizing Antibody Titers;Seroprevalence of HPV Neutralizing Antibodies;—

Countries

China

Contacts

Public ContactWang Wuliang

The Second Affiliated Hospital of Zhengzhou University

wangwuliang888@sina.com+86 139 3840 6398

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026